Valerie Su

Associate

---

Valerie joined the T1D Fund in August 2024. Prior to joining the Fund, she worked at Sanofi as a Scientist, driving early drug discovery projects for autoimmune diseases using various modalities, including antibodies, small molecules, and NANOBODY® molecules. She also completed a 6-month internal internship in External Innovation, where she identified the current challenges and competitive landscape for transplant innovative therapies and prioritized the external opportunities in line with Sanofi’s portfolio.

Valerie completed her Ph.D. in Pharmacology at Yale University in the laboratory of David Calderwood, where she studied molecular regulators of integrin and cerebral cavernous malformation signaling pathways. Valerie received her B.A. in Molecular and Cell Biology from the University of California, Berkeley.